Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 11 Beta-(4-dimethylaminophenyl)-17 Alpha-hydroxy-17 Beta-(3-hydroxypropyl)-13 Alpha-methyl-4,9-gonadien-3-one
2. Zk 299
3. Zk 98.299
4. Zk 98299
5. Zk-299
6. Zk-98299
1. 96346-61-1
2. Onapristone [inn]
3. Zk-98299
4. Zk-299
5. Zk98299
6. H6h7g23o3n
7. Zk299
8. Onapristone (inn)
9. Onapristonum [latin]
10. Onapristona [spanish]
11. Onapristona
12. Onapristonum
13. Zk 299
14. (8s,11r,13r,14s,17s)-11-(4-(dimethylamino)phenyl)-17-hydroxy-17-(3-hydroxypropyl)-13-methyl-1,2,6,7,8,11,12,13,14,15,16,17-dodecahydro-3h-cyclopenta[a]phenanthren-3-one
15. Ccris 6530
16. Zk 98299
17. Unii-h6h7g23o3n
18. Zk 98.299
19. Xe 299
20. Onapristone [mi]
21. Schembl8740
22. Onapristone [who-dd]
23. Gtpl2882
24. Tetrafluoroethylene Dimethylamine
25. Chembl1908373
26. Dtxsid90242210
27. Ivv-1001
28. Zinc3831947
29. Bdbm50366558
30. Nsc792824
31. Akos025311420
32. Db12637
33. Nsc-792824
34. (8s,11r,13r,14s,17s)-11-(4-dimethylaminophenyl)-17-hydroxy-17-(3-hydroxypropyl)-13-methyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one
35. 11beta-(p-(dimethylamino)phenyl)-17alpha-hydroxy-17-(3-hydroxypropyl)-13alpha-estra-4,9-dien-3-one
36. Bo161274
37. Estra-4,9-dien-3-one, 11-(4-(dimethylamino)phenyl)-17-hydroxy-17-(3-hydroxypropyl)-, (11-beta,13-alpha,17-alpha)-
38. Hy-106389
39. Cs-0025702
40. D09571
41. Q27088181
42. (8s,11r,13r,14s,17s)-11-(4-(dimethylamino)phenyl)-17-hydroxy-17-(3-hydroxypropyl)-13-methyl-6,7,8,11,12,13,14,15,16,17-decahydro-1h-cyclopenta[a]phenanthren-3(2h)-one
43. (8s,11r,13r,14s,17s)-11-[4-(dimethylamino)phenyl]-17-hydroxy-17-(3-hydroxypropyl)-13-methyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one
44. 11.beta.-(p-(dimethylamino)phenyl)-17.alpha.-hydroxy-17-(3-hydroxypropyl)-13.alpha.-estra-4,9-dien-3-one
45. Estra-4,9-dien-3-one, 11-[4-(dimethylamino)phenyl]-17-hydroxy-17-(3-hydroxypropyl)-, (11.beta.,13.alpha.,17.alpha.)-
46. Estra-4,9-dien-3-one,11-[4-(dimethylamino)phenyl]-17-hydroxy-17-(3-hydroxypropyl)-,(11b,13a,17a)-
| Molecular Weight | 449.6 g/mol |
|---|---|
| Molecular Formula | C29H39NO3 |
| XLogP3 | 3.2 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 5 |
| Exact Mass | 449.29299411 g/mol |
| Monoisotopic Mass | 449.29299411 g/mol |
| Topological Polar Surface Area | 60.8 Ų |
| Heavy Atom Count | 33 |
| Formal Charge | 0 |
| Complexity | 836 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 5 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Fertility Agents, Female
Compounds which increase the capacity to conceive in females. (See all compounds classified as Fertility Agents, Female.)
Antineoplastic Agents
Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)
Hormone Antagonists
Chemical substances which inhibit the function of the endocrine glands, the biosynthesis of their secreted hormones, or the action of hormones upon their specific sites. (See all compounds classified as Hormone Antagonists.)
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Onapristone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Onapristone, including repackagers and relabelers. The FDA regulates Onapristone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Onapristone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Onapristone supplier is an individual or a company that provides Onapristone active pharmaceutical ingredient (API) or Onapristone finished formulations upon request. The Onapristone suppliers may include Onapristone API manufacturers, exporters, distributors and traders.
click here to find a list of Onapristone suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Onapristone DMF (Drug Master File) is a document detailing the whole manufacturing process of Onapristone active pharmaceutical ingredient (API) in detail. Different forms of Onapristone DMFs exist exist since differing nations have different regulations, such as Onapristone USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Onapristone DMF submitted to regulatory agencies in the US is known as a USDMF. Onapristone USDMF includes data on Onapristone's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Onapristone USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Onapristone suppliers with USDMF on PharmaCompass.
Onapristone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Onapristone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Onapristone GMP manufacturer or Onapristone GMP API supplier for your needs.
A Onapristone CoA (Certificate of Analysis) is a formal document that attests to Onapristone's compliance with Onapristone specifications and serves as a tool for batch-level quality control.
Onapristone CoA mostly includes findings from lab analyses of a specific batch. For each Onapristone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Onapristone may be tested according to a variety of international standards, such as European Pharmacopoeia (Onapristone EP), Onapristone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Onapristone USP).
LOOKING FOR A SUPPLIER?
